News | April 19, 2010

SNM Stresses Long-Term Solution for Medicare Cuts

April 19, 2010 - President Barak Obama signed a bill granting temporary relief through June 1, 2010, from looming cuts to Medicare reimbursement rates, however, Michael Graham, Ph.D., M.D., president of the Society of Nuclear Medicine (SNM), stresses a need for a long-term solution.

“This is good news, and we are encouraged that the President has signed a bill to delay reimbursement cuts to medical imaging,” said Dr. Graham. “This extension may have bought us a little more time, but we are still in great need of a long-term solution that does not block access to medical services for Medicare patients.”

Graham added that the danger to the medical community is “very real” and advises that a long-term fix is needed to solve this persistent threat. “We urge Congress to take action now to stop this waiting game and ensure access to the tests patients need.”

“Medical imaging has come under greater threat than any other medical service,” said Robert W. Atcher, Ph.D., M.B.A., chair of SNM’s Government Relations Committee. “Nuclear medicine has seen greater cuts than other imaging modalities and is poised on the brink of disaster. It is a disservice to our profession and the patients we serve not to reimburse these tests at adequate levels.”

This recent short-term fix delays cuts to medical imaging through June 1, by which time Congress will have to take further action to ensure access for patients. After the temporary fix expires, physicians will once again face severe cuts in the level of reimbursement they receive for caring for Medicare patients. In the past, Congress has failed to approve a permanent fix to the Sustainable Growth Rate (SGR), instead passing a series of one-year patches to prevent proposed cuts. After the temporary fix expires, physicians will once again face severe cuts in the level of reimbursement they receive for caring for Medicare patients.

For more information: www.snm.org

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...